AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SURGICAL INNOVATIONS GROUP PLC

Director's Dealing Sep 11, 2018

7938_dirs_2018-09-11_a244d4de-88ec-41b0-a651-56df980917b2.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4103A

Surgical Innovations Group PLC

11 September 2018

Surgical Innovations Group plc

("the Company")

Director/PDMR Shareholdings

The Company was notified on 11 September 2018 that on 11 September 2018 Nigel Rogers, Executive Chairman, purchased 416,830 ordinary shares of 1 penny each in the Company ("Shares") for his ISA at a price of 3.25p per Share in an off-market transaction from Hardy Transaction Management Limited, which is wholly owned by Paul Hardy, a Non-Executive Director of the Company.

Following the transaction, the aggregate beneficial holding of Nigel Rogers in the Company is 6,276,830 Shares, representing 0.80% of the issued share capital and the beneficial holding of Paul Hardy is 5,808,711 Shares, representing 0.74% of the issued share capital.

For further information please contact:

Surgical Innovations Group plc www.sigroupplc.com
Nigel Rogers, Executive Chairman Tel: 0113 230 7597
Melanie Ross, COO & CFO
WH Ireland Limited (NOMAD & Broker) Tel: 0113 394 6600
Tim Feather

Chris Viggor
Walbrook PR (Financial PR & Investor Relations) Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391303

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Nigel Rogers

2

Reason for the notification

a)

Position/status

Executive Chairman

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Surgical Innovations Group plc

b)

LEI

2138004GHGUH3HUZE156

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

GB0004016704

b)

Nature of the transaction

Purchase of ordinary shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
3.25 pence 416,830

d)

Aggregated information

-     Aggregated volume

-     Price

416,830

3.25 pence

e)

Date of the transaction

11 September 2018

f)

Place of the transaction

Off-market

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Paul Hardy

2

Reason for the notification

a)

Position/status

Non-Executive Director

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Surgical Innovations Group plc

b)

LEI

2138004GHGUH3HUZE156

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

GB0004016704

b)

Nature of the transaction

Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s) Volume(s)
3.25 pence 416,830

d)

Aggregated information

-     Aggregated volume

-     Price

416,830 ordinary shares

3.25 pence

e)

Date of the transaction

11 September 2018

f)

Place of the transaction

Off-market

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

DSHGCGDCDDBBGIB

Talk to a Data Expert

Have a question? We'll get back to you promptly.